1. Home
  2. SGHT

SGHT

Sight Sciences Inc.

Logo Sight Sciences Inc.

Health Care

Medical Specialities

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Founded: 2011 Country:
United States
United States
Employees: N/A City: MENLO PARK
Market Cap: 254.7M IPO Year: 2021
Target Price: $5.00 AVG Volume (30 days): 203.1K
Analyst Decision: Hold Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.14 EPS Growth: N/A
52 Week Low/High: $1.04 - $11.20 Next Earning Date: 05-02-2024
Revenue: $81,056,000 Revenue Growth: 13.63%
Revenue Growth (this year): 2.76% Revenue Growth (next year): 10.85%

Share on Social Networks: